To access the full text documents, please follow this link: http://hdl.handle.net/2445/53332
dc.contributor.author | Saurí Duran, Jaume |
---|---|
dc.contributor.author | Millán, D. |
dc.contributor.author | Suñé i Negre, Josep M. (Josep Maria) |
dc.contributor.author | Pérez Lozano, Pilar |
dc.contributor.author | Sarrate, R. (Rocío) |
dc.contributor.author | Fábregas, A. (Anna) |
dc.contributor.author | Carrillo Sánchez, Carolina |
dc.contributor.author | Miñarro Carmona, Montserrat |
dc.contributor.author | Ticó Grau, Josep R. |
dc.contributor.author | García Montoya, Encarna |
dc.date | 2014-04-08T09:05:35Z |
dc.date | 2014-04-08T09:05:35Z |
dc.date | 2014-01-30 |
dc.date | 2014-04-08T09:05:36Z |
dc.identifier.citation | 0378-5173 |
dc.identifier.citation | 630651 |
dc.identifier.uri | http://hdl.handle.net/2445/53332 |
dc.format | 8 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier B.V. |
dc.relation | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.ijpharm.2013.11.029 |
dc.relation | International Journal of Pharmaceutics, 2014, vol. 461, num. 1-2, p. 38-45 |
dc.relation | http://dx.doi.org/10.1016/j.ijpharm.2013.11.029 |
dc.rights | (c) Elsevier B.V., 2014 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Comprimits (Medicina) |
dc.subject | Medicació oral |
dc.subject | Excipients |
dc.subject | Control de qualitat |
dc.subject | Medicaments d'alliberament retardat |
dc.subject | Tecnologia farmacèutica |
dc.subject | Pólvores (Farmàcia) |
dc.subject | Tablets (Medicine) |
dc.subject | Oral medication |
dc.subject | Excipients |
dc.subject | Quality control |
dc.subject | Delayed-action drugs |
dc.subject | Pharmaceutical technology |
dc.subject | Powders (Pharmacy) |
dc.title | The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |